What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2026-03-31 compared with 2025-04-15 · 16 added, 16 removed, 35 unchanged (48% of the section changed)

17 unchanged sentences

Fourth Quarter

of December 31, 2024, we had 2,808,071 shares of our Common Stock, par value $0.00001, issued and outstanding.

There were approximately

25,000 beneficial owners of our Common Stock.

is limited trading activity in our securities, and there can be no assurance that a regular trading market for our common stock will

be sustained.

of December 31, 2024, we had 2,808,071 shares of our common stock outstanding held by 96 shareholders of record, 0 shares of our Series

A Preferred Stock outstanding and 0 shares of our series B Preferred Stock.

of December 31, 2025, we had 5,879,741 shares of our common stock, par value $0.00001, issued and outstanding held by 96

shareholders of record and approximately 25,000 beneficial owners, 0 shares of our Series A Preferred Stock outstanding and 0 shares of our series B Preferred

have never paid a cash dividend on our common stock.

8 unchanged sentences

of the Securities Act and/or Regulation S under the Securities Act.

January 1, 2022 and December 31, 2022 the Company issued 8,215 shares of common stock to warrant holders upon exercise of $23,000 in

January 1, 2023 and December 31, 2023 the Company issued 19,656 shares of restricted common stock for services valued at $138,547.

On September 6, 2024, the Company

agreed to sell and issue to investors unregistered Series A Common Stock Purchase Warrants (the “Series A Warrants”) to purchase

up to 5,000,000 shares of Common Stock and unregistered Series B Common Stock Purchase Warrants (the “Series B Warrants,”

and collectively with the Series A Warrants, the “Common Warrants”) to purchase up to 5,000,000 shares of Common Stock.

Common Warrants will be exercisable on the effective date the Company obtains stockholder approval (the “Stockholder Approval”)

of the issuance of the shares underlying the exercise of the Common Warrants (the “Common Warrant Shares”), at an exercise

price of $0.43 per share.

The Series A Warrants will expire five years following the Stockholder Approval and the Series B Warrants will

expire 18 months following the Stockholder Approval.

January 1, 2024 and December 31, 2024 the Company issued 12,500 shares of restricted common stock for services valued at $90,000.

Between January 1, 2025 and December 31, 2025 the Company issued 100,000 shares of restricted common stock for services

valued at $135,000.

of the securities referred to, above, were issued without registration under the Securities Act of 1933, as amended (the “Securities

1 unchanged sentence

D promulgated thereunder.

6 – SELECTED FINANCIAL DATA

On February 11, 2026, the Company

consummated a public offering of (i) 5,259,999 shares of the Company’s common stock, par value $0.00001 per share at an offering

price of $0.35 per share of common stock, and (ii) pre-funded warrants to purchase up to 454,287 shares of common stock, at an offering

price of $0.3499 per pre-funded warrant and (iii) accompanying series x warrants to purchase up to 11,428,572 shares of common stock and

accompanying Series X Warrants.

Wainwright & Co., LLC acted as the placement agent in connection with the offering and received

a cash fee of 7% in the amount of $140,000 and was issued placement agent warrants to purchase up to 400,000 shares of common stock.

shares of common stock, pre-funded warrants, series x warrants, placement agent warrants, and the shares of common stock underlying the

pre-funded warrants, series x warrants, and placement agent warrants issued in the offering were offered pursuant to the Company’s

registration statement on Form S-1, as amended (File No.

333-293126) initially filed with the SEC under the Securities Act, on February

2, 2026, and declared effective by the SEC on February 9, 2026.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity